MFRM

Pharmaceutical preparations for treating the onset and progression of oxidative stress in age-related diseases, namely, dry eye disease, glaucoma, cataract, macular degeneration (AMD), retinal degenerations, neurodegenerative disorders, noise and sonic blast induced hearing loss, and traumatic neural tissue injury; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of hearing loss